Currently predicting for Thu, 4 Jun 2026

SAVA Prediction Chart

SAVA Predictions History

Latest community submissions for SAVA.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 8, 2025 $3.09 -3.20% $3.20 X 96.49% 0
Dec 8, 2025 $3.13 -2.00% $3.20 X 97.69% 0
Dec 8, 2025 Bullish $3.20 V 1
Oct 10, 2025 $4.07 -2.78% $3.74 V 91.08% 1
Oct 10, 2025 $4.12 -1.74% $3.74 V 89.91% 1
Oct 10, 2025 Bullish $3.74 X 0
Sep 24, 2025 $3.33 -2.41% $3.26 V 97.91% 1
Sep 24, 2025 $3.36 -1.50% $3.26 V 96.97% 1
Sep 24, 2025 Bullish $3.26 V 0
Jul 10, 2025 $2.16 -1.42% $2.16 V 99.95% 10
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SAVA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CASSAVA SCIENCES INC.
Cassava Sciences
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sci...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE